カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の多血小板血漿（PRP）市場2023-2030：種類別（Pure PRP、LR-PRP）、用途別（整形外科、スポーツ医学、美容外科）、エンドユーザー別、地域別

【英語タイトル】Platelet Rich Plasma (PRP) Market Size, Share & Trends Analysis Report By Type (Pure, Leukocyte Rich), By Application (Orthopedics, Sports Medicine, Cosmetic Surgery), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23JUN088）・商品コード：GRV23JUN088
・発行会社（調査会社）：Grand View Research
・発行日：2023年5月12日
・ページ数：110
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：バイオ
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Grand View Research社の市場調査書によると、世界の多血小板血漿（PRP）市場規模が、予測期間中（2023年～2030年）に年平均15.1％増加し、2030年までに19.4億ドルへ達すると見込まれています。本調査書では、多血小板血漿（PRP）の世界市場を調査対象とし、調査手法・範囲、市場定義、エグゼクティブサマリー、市場変動・動向・範囲、種類別（Pure PRP、LR-PRP、その他）分析、用途別（整形外科、スポーツ医学、美容外科、皮膚科、その他）分化、エンドユーザー別（病院、診療所、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、企業情報などについて調査・分析し、まとめています。なお、こちらに掲載されている企業情報には、Johnson & Johnson、Arthrex, Inc.、EmCyte Corporation、DR. PRP America, Llc、Juventix、Terumo Corporation、Zimmer Biomet、Stryker、Apex Biologix、Celling Biosciencesなどが含まれています。
・調査手法・範囲
・市場定義
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界多血小板血漿（PRP）の市場規模：種類別
- Pure PRPの市場規模
- LR-PRPの市場規模
- その他多血小板血漿（PRP）の市場規模
・世界多血小板血漿（PRP）の市場規模：用途別
- 整形外科における市場規模
- スポーツ医学における市場規模
- 美容外科における市場規模
- 皮膚科における市場規模
- その他用途における市場規模
・世界多血小板血漿（PRP）の市場規模：エンドユーザー別
- 病院における市場規模
- 診療所における市場規模
- その他エンドユーザーにおける市場規模
・世界多血小板血漿（PRP）の市場規模：地域別
- 北米の多血小板血漿（PRP）市場規模
- ヨーロッパの多血小板血漿（PRP）市場規模
- アジア太平洋の多血小板血漿（PRP）市場規模
- 中南米の多血小板血漿（PRP）市場規模
- 中東・アフリカの多血小板血漿（PRP）市場規模
・企業情報

多血小板血漿（PRP）市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の多血小板血漿（PRP）市場規模は、2023年から2030年にかけて15.1%のCAGRを記録し、2030年には19.4億米ドルに達する見込みです。美容整形手術の増加、国内外のスポーツイベントの増加、血漿ベースの治療法における研究の拡大が業界の成長を促進しています。さらに、多血小板血漿（PRP）ベースの治療法の研究開発活動と規制当局の承認は、主要な市場促進要因です。

現在、スポーツ外傷、整形外科疾患、筋骨格系疾患の治療にPRPを使用する需要が急増しています。PRPは成長因子を濃縮し、治癒時間を大幅に短縮することができます。PRPはまた、再生医療分野で主要な用途を見つけ、創傷治癒と修復カスケードをスピードアップする各患者のためのカスタム製品として機能します。

多血小板血漿（PRP）は、形成外科において、身体自身の自然な組織修復プロセスを利用して、形態と機能の改善を達成するために、有望な結果をもたらしながら発展してきました。使いやすいこと、患者の細胞を利用して安価に製造できること、副作用のリスクがほとんどないことなどの特徴が、PRP療法が提供する主な利点です。しかし、治療には時間がかかり、複数回のセッションが必要です。さらに、肌の若返り、肌の色素沈着、ニキビ跡の治療、ヴァンパイアフェイシャルの際の肌の引き締めにも役立ちます。PRPは、毛包の形成と維持に効果のある植毛用のサプリメントとして使用されています。このように、多血小板血漿の広範な用途は業界の成長を促進すると予想されています。

さらに、主要企業は市場参入のためにM&A、製品開発、事業拡大などの戦略的イニシアチブを実施しています。2021年9月、Terumo BCTは米国における顧客基盤の拡大を視野に入れ、カルタゴのラ・リマに新たな製造施設を開設し、コスタリカでの存在感を高めました。2020年2月、EmCyte社はセントレピッド血小板濃縮システムを擁するCellmedix Holdings LLCを買収しました。これにより、同社の製品ポートフォリオが拡大し、市場での存在感が向上しました。

COVID-19を受け、市場はサプライチェーンの混乱、リソース配分の制約、患者アクセス活動の阻害などの理由で大きく後退しました。しかし、2022年1月までに市場は安定化し、需要と供給の正常化が進み、ユーザーと患者は多血小板血漿（PRP）へのアクセスを回復しました。

多血小板血漿（PRP）市場レポートハイライト

– タイプ別では、純多血小板血漿（PRP）セグメントが2022年に51.8%超の最大売上シェアを占めましたが、これはさまざまな治療領域で広く使用されていることと、世界中で適応外使用の需要が高まっているためです。

– 用途別では、整形外科のさまざまな用途でPRPを調査する研究数が急増しているため、整形外科分野が2022年に市場の首位に立ちました。しかし、皮膚科、スポーツ医学、潰瘍治癒などの他のセグメントは、予測期間中により速い速度で成長すると予想されます。

– 病院の最終用途セグメントは、2022年に最大の収益シェアを占めました。これは、PRPベースの療法を提供する病院数の増加や、近年の変形性膝関節症の症例数の増加に起因しています。

– 北米は、RPPの幅広い用途、PRPベースの治療に対する意識の高まり、整形外科症例の増加により、2022年の世界市場で首位に立ちました。

– アジア太平洋地域は、美容整形手術件数の増加と医療ツーリズム産業の成長により、今後大幅な成長が見込まれています。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and Forecast Timeline
1.3 Information Procurement
1.3.1 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details of Primary Research
1.5 Information or Data Analysis
1.5.1 Platelet Rich Plasma (PRP) market: segment revenue and growth analysis
1.5.2 Sports medicine market: segment revenue and growth analysis
1.5.3 Platelet Rich Plasma (PRP)-based ulcer healing market: segment revenue and growth analysis
1.5.3.1 Platelet Rich Plasma (PRP)-based ulcer healing market: segment definition
1.5.3.1.1 Non-Healing Ulcers
1.5.3.1.1.1 Diabetic Ulcers
1.5.3.1.1.2 Pressure Ulcers
1.5.3.1.1.3 Pyoderma gangrenosum
1.5.3.1.1.4 Venous ulcers
1.5.4 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.8 Market: CAGR Calculation
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
Chapter 2 Market Definitions
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Market Summary
Chapter 4 Platelet Rich Plasma Market Variables, Trends & Scope
4.1 Market Trends & Outlook
4.2 Market Segmentation & Scope
4.3 Market Driver Analysis
4.3.1 Rise In The Incidence Of Orthopedic Disorders And Sports Injuries
4.3.2 Increasing Number Of Cosmetic Surgery Procedures
4.3.3 Extending Medical Applications Of Platelet Rich Plasma
4.3.4 Increasing Number Of Evidence-Based Studies For PRP-Based Wound Healing
4.4 Market Restraint Analysis
4.4.1 High Costs Associated With PRP Products
4.5 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
4.6 Porter’s Five Forces Analysis
4.7 Covid-19 Impact Analysis
Chapter 5 Platelet Rich Plasma Market – Segment Analysis, By Type, 2018 – 2030 (Usd Million)
5.1 Platelet Rich Plasma Market: Type Movement Analysis
5.2 Pure PRP
5.2.1 Pure PRP Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3 Leukocyte Rich PRP
5.3.1 Leukocyte Rich PRP Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.4 Others
5.4.1 Other Type Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 6 Platelet Rich Plasma Market – Segment Analysis, By Application, 2018 – 2030 (Usd Million)
6.1 Platelet Rich Plasma Market: Application Movement Analysis
6.2 Orthopedics
6.2.1 Orthopedics Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3 Sports Medicine
6.3.1 Sport Medicine Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4 Cosmetic Surgery
6.4.1 Platelet Rich Plasma (PRP) Market Estimates And Forecast For Cosmetic Surgery, 2018 – 2030
6.5 Dermatology
6.5.1 Coverage Scneario: U.S. Centers For Medicare & Medicaid Services
6.5.2 Platelet Rich Plasma (PRP) Market estimates and forecast for Dermatology, 2018 – 2030
6.5.3 Ulcer healing
6.5.3.1 Platelet Rich Plasma (PRP) Market estimates and forecast for ulcer healing, 2018 – 2030
6.5.3.2 Venous ulcers
6.5.3.2.1 Platelet Rich Plasma (PRP) Market estimates and forecast for venous ulcers, 2018 – 2030
6.5.3.3 Traumatic ulcers
6.5.3.3.1 Platelet Rich Plasma (PRP) Market estimates and forecast for traumatic ulcers, 2018 – 2030
6.5.3.4 Pyoderma gangrenosum ulcers
6.5.3.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for pyoderma gangrenosum ulcers, 2018 – 2030
6.5.3.5 Diabetic ulcers
6.5.3.5.1 Platelet Rich Plasma (PRP) Market estimates and forecast for diabetic ulcers, 2018 – 2030
6.5.3.6 Trophic ulcers
6.5.3.6.1 Platelet Rich Plasma (PRP) Market estimates and forecast for trophic ulcers, 2018 – 2030
6.5.3.7 Vasculitic ulcers
6.5.3.7.1 Platelet Rich Plasma (PRP) Market estimates and forecast for vasculitic ulcers, 2018 – 2030
6.5.4 Others
6.5.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for others, 2018 – 2030
6.6 Ophthalmic Surgery
6.6.1 Platelet Rich Plasma (PRP) Market Estimates And Forecast For Ophthalmic Surgery, 2018 – 2030
6.7 Neurosurgery
6.7.1 Platelet Rich Plasma (PRP) Market Estimates And Forecast For Neurosurgery, 2018 – 2030
6.8 General Surgery
6.8.1 Platelet Rich Plasma (PRP) Market Estimates And Forecast For General Surgery, 2018 – 2030
6.9 Others
6.9.1 Platelet Rich Plasma (PRP) Market Estimates And Forecast For Others, 2018 – 2030
Chapter 7 Platelet Rich Plasma (PRP) Market – Segment Analysis, by End Use, 2018 – 2030 (USD Million)
7.1 Platelet Rich Plasma (PRP): End-use Movement Analysis
7.2 Hospitals
7.2.1 Hospitals Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.3 Clinics
7.3.1 Clinics Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.4 Others
7.4.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 8 Platelet Rich Plasma (PRP) Market – Segment Analysis, By Region, 2018 – 2030 (Usd Million)
8.1 Platelet Rich Plasma (PRP) Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 Key Country Dynamics
8.2.2.2 Competitive Scenario
8.2.2.3 Prevalence Insights
8.2.2.4 Regulatory Framework
8.2.2.5 Reimbursement Structure
8.2.2.6 U.S. Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Key Country Dynamics
8.2.3.2 Competitive Scenario
8.2.3.3 Prevalence Insights
8.2.3.4 Regulatory Framework
8.2.3.5 Reimbursement Structure
8.2.3.6 Canada Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3 Europe
8.3.1 Europe Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.3.2 Germany
8.3.2.1 Key Country Dynamics
8.3.2.2 Competitive Scenario
8.3.2.3 Prevalence Insights
8.3.2.4 Regulatory Framework
8.3.2.5 Reimbursement Structure
8.3.2.6 Germany Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.3 UK
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.3 Prevalence Insights
8.3.3.4 Regulatory Framework
8.3.3.5 Reimbursement Structure
8.3.3.6 UK Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.4 Spain
8.3.4.1 Key Country Dynamics
8.3.4.2 Competitive Scenario
8.3.4.3 Prevalence Insights
8.3.4.4 Regulatory Framework
8.3.4.5 Reimbursement Structure
8.3.4.6 Spain Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.5 France
8.3.5.1 Key Country Dynamics
8.3.5.2 Competitive Scenario
8.3.5.3 Prevalence Insights
8.3.5.4 Regulatory Framework
8.3.5.5 Reimbursement Structure
8.3.5.6 France Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.6 Italy
8.3.6.1 Key Country Dynamics
8.3.6.2 Competitive Scenario
8.3.6.3 Prevalence Insights
8.3.6.4 Regulatory Framework
8.3.6.5 Reimbursement Structure
8.3.6.6 Italy Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.7 Denmark
8.3.7.1 Key Country Dynamics
8.3.7.2 Competitive Scenario
8.3.7.3 Prevalence Insights
8.3.7.4 Regulatory Framework
8.3.7.5 Reimbursement Structure
8.3.7.6 Denmark Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.8 Sweden
8.3.8.1 Key Country Dynamics
8.3.8.2 Competitive Scenario
8.3.8.3 Prevalence Insights
8.3.8.4 Regulatory Framework
8.3.8.5 Reimbursement Structure
8.3.8.6 Sweden Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.9 Norway
8.3.9.1 Key Country Dynamics
8.3.9.2 Competitive Scenario
8.3.9.3 Prevalence Insights
8.3.9.4 Regulatory Framework
8.3.9.5 Reimbursement Structure
8.3.9.6 Norway Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive Scenario
8.4.2.3 Prevalence Insights
8.4.2.4 Regulatory Framework
8.4.2.5 Reimbursement Structure
8.4.2.6 Japan Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.3 China
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 Prevalence Insights
8.4.3.4 Regulatory Framework
8.4.3.5 Reimbursement Structure
8.4.3.6 China Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.4 India
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.4.3 Prevalence Insights
8.4.4.4 Regulatory Framework
8.4.4.5 Reimbursement Structure
8.4.4.6 India Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.5 South Korea
8.4.5.1 Key Country Dynamics
8.4.5.2 Competitive Scenario
8.4.5.3 Prevalence Insights
8.4.5.4 Regulatory Framework
8.4.5.5 Reimbursement Structure
8.4.5.6 South Korea Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.6 Australia
8.4.6.1 Key Country Dynamics
8.4.6.2 Competitive Scenario
8.4.6.3 Prevalence Insights
8.4.6.4 Regulatory Framework
8.4.6.5 Reimbursement Structure
8.4.6.6 Australia Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.7 Thailand
8.4.7.1 Key Country Dynamics
8.4.7.2 Competitive Scenario
8.4.7.3 Prevalence Insights
8.4.7.4 Regulatory Framework
8.4.7.5 Reimbursement Structure
8.4.7.6 Thailand Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Prevalence Insights
8.5.2.4 Regulatory Framework
8.5.2.5 Reimbursement Structure
8.5.2.6 Brazil Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 Prevalence Insights
8.5.3.4 Regulatory Framework
8.5.3.5 Reimbursement Structure
8.5.3.6 Mexico Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 Prevalence Insights
8.5.4.4 Regulatory Framework
8.5.4.5 Reimbursement Structure
8.5.4.6 Argentina Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.6 Middle East and Africa
8.6.1 Middle-East And Africa Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 Key Country Dynamics
8.6.2.2 Competitive Scenario
8.6.2.3 Prevalence Insights
8.6.2.4 Regulatory Framework
8.6.2.5 Reimbursement Structure
8.6.2.6 South Africa Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.6.3 UAE
8.6.3.1 Key Country Dynamics
8.6.3.2 Competitive Scenario
8.6.3.3 Prevalence Insights
8.6.3.4 Regulatory Framework
8.6.3.5 Reimbursement Structure
8.6.3.6 UAE Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.6.4 Saudi Arabia
8.6.4.1 Key Country Dynamics
8.6.4.2 Competitive Scenario
8.6.4.3 Prevalence Insights
8.6.4.4 Regulatory Framework
8.6.4.5 Reimbursement Structure
8.6.4.6 Saudi Arabia Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.6.5 Kuwait
8.6.5.1 Key Country Dynamics
8.6.5.2 Competitive Scenario
8.6.5.3 Prevalence Insights
8.6.5.4 Regulatory Framework
8.6.5.5 Reimbursement Structure
8.6.5.6 Kuwait Platelet Rich Plasma Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 9 Company Profile
9.1 Company Categorization
9.2 Strategy Mapping
9.2.1 New Product Launch
9.2.2 Partnerships
9.2.3 Acquisition
9.2.4 Collaboration
9.2.5 FUNDING
9.3 Key Company Market Share Analysis, 2022
9.4 Company Profiles
9.4.1 Johnson & Johnson
9.4.1.1 Company overview
9.4.1.2 DePuy Synthes
9.4.1.2.1 Company overview
9.4.1.3 Financial Performance
9.4.1.4 Product benchmarking
9.4.1.5 Strategic initiatives
9.4.2 Arthrex, Inc.
9.4.2.1 Company overview
9.4.2.2 Financial Performance
9.4.2.3 Product benchmarking
9.4.2.4 Strategic initiatives
9.4.3 EmCyte Corporation
9.4.3.1 Company overview
9.4.3.2 Product benchmarking
9.4.3.3 Strategic initiatives
9.4.4 DR. PRP America, Llc
9.4.4.1 Company overview
9.4.4.2 Product benchmarking
9.4.5 Juventix
9.4.5.1 Company overview
9.4.5.2 Financial Performance
9.4.5.3 Product benchmarking
9.4.6 Terumo Corporation
9.4.6.1 Company overview
9.4.6.2 Terumo Bct, Inc.
9.4.6.2.1 Company overview
9.4.6.3 Financial Performance
9.4.6.4 Product benchmarking
9.4.6.5 Strategic initiatives
9.4.7 Zimmer Biomet
9.4.7.1 Company overview
9.4.7.2 Financial Performance
9.4.7.3 Product benchmarking
9.4.7.4 Strategic initiatives
9.4.8 Stryker
9.4.8.1 Company overview
9.4.8.2 Financial Performance
9.4.8.3 Product benchmarking
9.4.8.4 Strategic initiatives
9.4.9 Apex Biologix
9.4.9.1 Company overview
9.4.9.2 Financial Performance
9.4.9.4 Product benchmarking
9.4.9.4 Strategic initiatives
9.4.10 Celling Biosciences
9.4.10.1 Company overview
9.4.10.2 Financial Performance
9.4.10.3 Product benchmarking
9.4.10.4 Strategic initiatives

List of Tables

Table 1 Global Platelet Rich Plasma (PRP) Market, By Region, 2018 - 2030 (USD Million)
Table 2 Global Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 3 Global Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 4 Global Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 5 North America Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
Table 6 North America Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 7 North America Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 8 North America Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 9 U.S. Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 10 U.S. Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 11 U.S. Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 12 Canada Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 13 Canada Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 14 Canada Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 15 Europe Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
Table 16 Europe Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 17 Europe Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 18 Europe Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 19 UK Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 20 UK Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 21 UK Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 22 Germany Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 23 Germany Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 24 Germany Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 25 France Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 26 France Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 27 France Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 28 Italy Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 29 Italy Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 30 Italy Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 31 Spain Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 32 Spain Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 33 Spain Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 34 Denmark Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 35 Denmark Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 36 Denmark Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 37 Sweden Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 38 Sweden Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 39 Sweden Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 40 Norway Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 41 Norway Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 42 Norway Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 47 Japan Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 48 Japan Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 49 Japan Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 50 China Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 51 China Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 52 China Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 53 India Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 54 India Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 55 India Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 56 Australia Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 57 Australia Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 58 Australia Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 59 South Korea Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 60 South Korea Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 61 South Korea Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 62 Thailand Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 63 Thailand Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 64 Thailand Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 65 Latin America Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
Table 66 Latin America Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 67 Latin America Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 68 Latin America Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 69 Brazil Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 70 Brazil Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 71 Brazil Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 72 Mexico Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 73 Mexico Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 74 Mexico Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 75 Argentina Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 76 Argentina Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 77 Argentina Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 78 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 82 South Africa Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 83 South Africa Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 84 South Africa Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 88 UAE Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 89 UAE Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 90 UAE Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 91 Kuwait Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 92 Kuwait Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 93 Kuwait Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)

★調査レポート[世界の多血小板血漿（PRP）市場2023-2030：種類別（Pure PRP、LR-PRP）、用途別（整形外科、スポーツ医学、美容外科）、エンドユーザー別、地域別] (コード：GRV23JUN088)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の多血小板血漿（PRP）市場2023-2030：種類別（Pure PRP、LR-PRP）、用途別（整形外科、スポーツ医学、美容外科）、エンドユーザー別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の全ゲノムシーケンス（WGS）市場2023-2030：製品別（器具、消耗品、サービス）、種類別、ワークフロー別、用途別、エンドユーザー別、地域別
  • 世界の遺伝子合成（研究用）市場2023-2030：方法別（固相、チップベース）、研究フェーズ別（前臨床、臨床）、用途別、サービス別、エンドユーザー別
  • 世界のin situハイブリダイゼーション（ISH）市場2023-2030：技術別、プローブ別、製品別、用途別、エンドユーザー別、地域別
  • 世界のカルシウムハイドロキシアパタイト（CaHA）フィラー市場2024-2030：用途別（顔のしわ・ひだ、あごの輪郭、脂肪萎縮症）、エンドユーザー別（メッドスパ、美容外科、病院）
  • 世界の乳がん針生検（コアニードルバイオプシー/CNB）市場2023-2030：技術別、エンドユーザー別（病院・診断研究所、学術・研究機関）、地域別
  • 世界の麻酔薬市場（～2027）：投与経路別（注射麻酔薬、吸入麻酔薬、静脈麻酔薬、局所麻酔薬）、麻酔種類別（局所麻酔、全身麻酔、鎮静）、薬物種類別（局所麻酔薬、全身麻酔薬）、用途別（整形外科、歯科外科、一般外科、美容外科）、エンドユーザー別（専門クリニック、病院、外来手術センター、製薬会社）、地域別
  • 世界の自給式呼吸器（SCBA）市場2023-2030：種類別（開放型SCBA、閉鎖型SCBA）、エンドユーザー別（消防、石油・ガス）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆